STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #304 by analyst upside · 2026-06-27
MYO
Myomo, Inc.
Healthcare · Market Cap $40M · P/E 0x
ANALYST PRICE TARGET
+329.1%
implied upside to consensus target
Current Price $1.03
Consensus Target $4.42
Bull Target $10.0
Bear Target $1.1
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
4
Hold
0
Sell
0
52-Week Low $0.6
52-Week High $2.38
YTD Return +4.0%
FUNDAMENTALS
Market Cap $40M
P/E Ratio (TTM) N/A
Forward P/E -4.1x
EPS (TTM) $-0.36
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $41M
Profit Margin -36.7%
52-WEEK RANGE
52-Week Low $0.6
52-Week High $2.38
Current Price $1.03
Bear Target $1.1
Bull Target $10.0
● Now $1.03 ● Target $4.42
TRADING DATA
Avg Volume 742K
YTD Return +4.0%
Analyst Count 5
Consensus Buy
Upside to Target +329.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Myomo, Inc. (MYO) is currently trading at $1.03 with a Wall Street consensus price target of $4.42, implying potential upside of 329.1% over the next 12 months. 5 analysts currently cover MYO, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $10.0, while the most cautious has a target of $1.1.

MYO operates in the Healthcare sector with a market capitalisation of $40M. The stock is up 4.0% year-to-date and is currently trading near the lower end of its 52-week range of $0.6 – $2.38.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MYO, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Ascendiant Capital — Reiterated
Buy → Buy 2026-06-08 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-11-21 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-09-22 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-08-12 31% win rate (48 calls)
Craig-Hallum — Reiterated
Buy → Buy 2025-06-23 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-06-05 Building track record
Craig-Hallum — Reiterated
Buy → Buy 2025-05-08 Building track record
Ascendiant Capital — Reiterated
Buy → Buy 2025-03-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
41
out of 100
Coverage depth
14/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →